Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in ocular gene therapy.

Teresa Borrás1

  • 1Department of Ophthalmology, University of North Carolina School of Medicine, 6109 Neuroscience Research Building, Campus Box 7041, 103 Mason Farm Road, Chapel Hill, NC 27599, USA. tborras@med.unc.edu

Experimental Eye Research
|May 14, 2003
PubMed
Summary

Recent gene therapy advances show promise for treating eye diseases. While challenges remain, encoding beneficial proteins has improved ocular conditions and even restored vision in animal models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRPV4 controls circadian and pathological ocular hypertension.

The Journal of physiology·2025
Same author

TRPV4 subserves physiological and pathological elevations in intraocular pressure.

Research square·2024
Same author

Genes as drugs for glaucoma: latest advances.

Current opinion in ophthalmology·2023
Same author

Deletion of transcription factor AP-2β from the developing murine trabecular meshwork region leads to progressive glaucomatous changes.

Journal of neuroscience research·2021
Same author

Generation of a Matrix Gla (Mgp) floxed mouse, followed by conditional knockout, uncovers a new Mgp function in the eye.

Scientific reports·2020
Same author

Author Correction: The LRRC8-mediated volume-regulated anion channel is altered in glaucoma.

Scientific reports·2020

Area of Science:

  • Ophthalmology
  • Gene Therapy
  • Molecular Biology

Background:

  • Significant increase in ocular gene therapy studies over the past 2-3 years.
  • Exploration of both viral and non-viral delivery systems for ocular applications.
  • Shift from reporter genes to genes with direct therapeutic potential.

Purpose of the Study:

  • To review the most recent advances in ocular gene therapy.
  • To highlight progress in experimental settings for anterior and posterior eye segments.
  • To discuss the potential for future clinical applications.

Main Methods:

  • Review of recent experimental studies in ocular gene therapy.
  • Administration of genes encoding beneficial proteins.
  • Use of various viral and non-viral delivery systems.

Related Experiment Videos

Main Results:

  • Improvements in ocular conditions in both anterior and posterior segments.
  • Restoration of vision in a congenitally blind animal model.
  • Encouraging outcomes in experimental gene therapy for eye diseases.

Conclusions:

  • Ocular gene therapy shows significant promise, with encouraging experimental results.
  • Further research into molecular biology of eye tissues and low immunogenicity vectors is crucial.
  • Gene therapy is moving closer to clinical application for treating eye diseases.